Internal Server Error

About CDIB Capital

CDIB Capital is a private equity firm founded in 2006. It is primarily based in Hong Kong, China. As of Oct 2026, CDIB Capital has a portfolio of 53 companies, comprising 53 funding rounds and 3 acquisitions. The firm primarily invests in companies based in China and Taiwan. Its portfolio is spread across a wide range of sectors from Life Sciences to Consumer. Its latest investment was a $***** Series B round in TMYTEK on Nov 02, 2024 which also saw participation from Amazing and EZconn. 
Overall CDIB Capital portfolio has seen 2 unicorns, 9 IPOs and 13 acquisitions including key companies like Casper, Indostar Capital Finance and The Coffee Bean & Tea Leaf. A lot of funds co-invest with CDIB Capital, with names like Alibaba Entrepreneurs Fund sharing a substantial percentage of its portfolio. 
CDIB Capital has a team of 29 people, including 14 partners.
Key Metrics
Founded Year
2006
Location
Hong Kong, China
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals

CDIB Capital's Portfolio

CDIB Capital has a portfolio of 53 companies. They have invested in a total of 53 companies. Their most recent investment was in TMYTEK (Series B round) on Nov 02, 2024. Here are the most recent investments by CDIB Capital:
Date
Company
Round
Amount
Co-Investors
Nov 02, 2024
Series B
1078
Sep 26, 2023
Series B
4188
Aug 27, 2023
Series C
6355
Dec 08, 2022
Series B
8581
CDIB Capital has acquired 3 companies. Their most recent acquisition was of Yuga on May 31, 2021. Here are the most recent acquisitions by CDIB Capital:
Acquisition Date
Company
Short Description
Total Funding
Founded Year
May 31, 2021
Producer of cosmetic packaging items
-
2007
Dec 18, 2025
Manufacturer of textile and leather speciality chemicals
-
1978
Mar 25, 2019
Retailer of women's apparel and accessories
-
1931
Here is the portfolio snapshot of CDIB Capital:
Investments by Year
The maximum number of investments were made in 2022
Investments by Year - The maximum number of investments were made in 2022# Investments20262024202220202018Year
Acquisitions by Year
The maximum number of acquisitions were made in 2019
Acquisitions by Year - The maximum number of acquisitions were made in 2019# Acquisitions2026202420222020Year
Portfolio by Location
Companies are primarily in China and Taiwan
Portfolio by LocationChinaTaiwan
Portfolio by Sector
Companies are primarily in Life Sciences
Portfolio by SectorLife SciencesConsumer

Team profile of CDIB Capital

CDIB Capital has a team of 29 members including 14 Partners and 11 Principals located in China, United States and 2 more locations. CDIB Capital's team does not sit on the board of any company as of now.
Here is a list of top team members in CDIB Capital:
Name
Designation
Location
Board Memberships
Contact Details
Partner
Hong Kong
-
-
Partner
Seoul
-
-
Partner
Hong Kong
-
-
Partner
Taipei
-
-
Partner
-
-
-
Partner
Hong Kong
-
-
Partner
Shanghai
-
-
Partner
New York City
-
-
Partner
Shenzhen
-
-
Partner
Hong Kong
-

Co-investors of CDIB Capital

Over the past 20 years, 106 investors have co-invested in CDIB Capital's portfolio companies.

  • Top Co-investors of CDIB Capital: 106 investors entered a company along with CDIB Capital. These include investors like Alibaba Entrepreneurs Fund (2 companies).

CDIB Capital News

•
US healthcare AI provider Aidoc raises $110m series DTech in Asia•Jul 24, 2025•AIdoc, CDIB Capital, TCV, AIC
•
QT Medical Closes USD12M Series B FinancingFinSMEs•Sep 27, 2023•QT Medical, CDIB Capital, Taiwania Capital, Cathay Capital and 2 others
•
Aidoc Raises $110 Million to Improve HealthcareCAESARS INTERACTIVE ENTERTAINMENT (UK) LIMITED•Jun 16, 2022•AIdoc, TCV, AIC, CDIB Capital
•
View more CDIB Capital News

FAQs about CDIB Capital

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford